
- Patient-Centered Oncology Care 2026
- Volume 32
- Issue Spec 15
Careology Shows How Remote Monitoring Works in 4 Very Different “Rooms”
Key Takeaways
- Careology “consumerizes” oncology home monitoring while preserving clinical rigor through an AI platform integrating wearables, patient-reported data, and EHR-connected clinician dashboards.
- Oncology Hematology Care piloted at-home CAR T/BiTE monitoring using continuous temperature sensing and ICE assessments, with automated fever alerts to patients and nurses at 100.4 °F.
During OncoVenture, Careology leaders described how their platform supports patients receiving CAR T-cell therapy at home in Ohio, extends Mayo Clinic’s reach in rural Florida, and powers payer care navigation.
As the first-ever session of OncoVenture opened at the 2026 Patient-Centered Oncology Care (PCOC) conference in Nashville, Tennessee, Paul Landau, CEO and founder of Careology, told attendees how the company grew out of his wife’s experience as a patient with Hodgkin lymphoma. She received treatment in 2016,relapsed in 2019, and went on to a successful stem cell transplant.
For Landau, caring for his wife revealed “the isolation, the 90% of time that you spend at home in between cycles of treatment, the onus on that person to make what can often be fairly clinical judgment calls as to what’s normal, what isn’t normal.”
Patients go into the hospital when they feel well, he said, then go home “to contend with all of those nasty toxicities and [adverse] effects.”
Careology, founded in the United Kingdom, seeks to bridge the gap between technology used in hospital settings and technology suitable for home settings, which, Landau said, calls for something very different. Careology, the first of 2 companies to present at OncoVenture, “blends clinical precision with consumer-grade design to deliver connected, personalized, proactive care, all through one AI [artificial intelligence]-powered platform,” according to its website. It is among the solution providers seeking to address the monitoring needs of patients receiving treatments that are moving into outpatient settings, such as chimeric antigen receptor (CAR) T-cell therapy or bispecific T-cell engagers (BiTEs).
Technology for home use had to be “consumerized,” Landau said, so that it would not feel “dry and stigmatizing and overtly clinical.” At the same time, “that real clinical rigor and efficacy” was retained. The company offers a patient app that links to wearables, a clinician dashboard called Careology Professional that integrates with the electronic health record, and a care navigation module called Careology Connect. Patients move among green, amber, and red statuses, giving care teams what Landau called an “early alert system.”
A Look at 4 Case Studies
Kimberly Shyu, Careology’s chief product officer, walked the PCOC audience through 4 deployments. In Cincinnati, Ohio, Oncology Hematology Care, part of The US Oncology Network, asked “a question that would have been kind of terrifying 2 or 3 years ago, which is: Can we monitor CAR T and BiTE therapy patients at home?” Patients wear a TempTraq patch that sends temperature data every 10 minutes, and caregivers complete a daily immune effector cell–associated encephalopathy assessment. At 100.4 °F, the system automatically logs a fever, pushes a notification telling the patient to call, and alerts the nurse. “The nurse already knows,” Shyu said.
In the Florida Panhandle, Mayo Clinic uses Careology to connect in-home nurses with a command center in Jacksonville, 3 to 4 hours away. “Nothing really starts in home until the command center says so,” Shyu said. A payer’s care navigators use Careology Connect to stratify and assign members. In the United Kingdom, Nuffield Health found that patients using Careology reported 21% more cases of mouth inflammation than a matched cohort, and the organization began prescribing a prophylactic mouthwash. “They changed what they prescribe because of the data,” Shyu said.
According to results published by Florida Blue, a cohort using Careology with care navigation saw 40% admission avoidance, $500 in savings per patient per month, and 95% patient satisfaction.1
Digging Into the Details
Scott Soefje, PharmD, MBA, BCOP, director of pharmacy cancer care services at Mayo Clinic, opened by noting that the previous day’s caregiver session had described the caregiver as “the one at 2 am that’s hearing everything. How does this system help caregivers?”
“Having worn those boots, I know what a tough role being a caregiver can be—looking after a loved one going through cancer, but also looking after yourself,” Landau said. Patients can invite family members into their Careology network to answer questions such as, “Has Mum taken her medications this morning? Is Dad sitting at home with a fever that he hasn’t let anyone know about?” That, he said, “stops every conversation always being about cancer.”
Soefje noted that a community practice had reported being on its fifth patient receiving CAR T. “How do you use this system to get to patient 50 or 60?”
Shyu said Oncology Hematology Care expects about 50 patients in its first year, and the company is starting slowly. “We can have all the digital tools in the world, but if they’re not actively looking at the dashboard to understand what’s happening, it’s not going to work,” she said. “Start slow, make sure that everything is working well operationally, and then you can scale.”
In response to a question from The American Journal of Managed Care® about the satisfaction figure, Landau said it was measured over approximately 6 months in a Florida Blue cohort. Keeping patients engaged depends on how the platform is deployed, he said. “It’s not your nurse or your navigator just going, ‘Hey, there’s this cool app called Careology. Go download it. We hope it helps.’ It’s introduced to you as part of your care.”
Soefje then turned to the clinician side. “We’ve all seen patient-reported dashboards that the clinicians just don’t open, right? What do we need to do to make it so that the clinician will actually open that and look at it?”
Landau said the key is early “lightbulb moments,” when a nurse realizes, “Wow, I can see that person sitting at home with a fever, or severe nausea…. We never would have known about that.” Red alerts also go to clinicians’ phones, so “if they are on a lunch break or on a coffee break and someone turns red, it’s not like no one’s going to see it for an hour.” Shyu added that Careology integrates with Epic at Mayo Clinic and with iKnowMed for The US Oncology Network. “We know that you don’t want to remember multiple passwords,” she said.
The final question came from Patty Koffman, cofounder of the CLL Society, whose husband is a 21-year survivor of chronic lymphocytic leukemia (CLL). She said such a tool “would take a tremendous burden off of caregivers who might stay up every night, every 3 hours, taking temperatures,” and asked how patients could get it.
Right now, Shyu said, Careology is a business-to-business venture in the United States, although it is offered free directly to consumers in the United Kingdom. “For now, at least—maybe in the future that will change,” she said.
Reference
- From pilot to program: Florida Blue expands cancer support for Medicare Advantage members. News release. Florida Blue. January 14, 2026. Accessed November 16, 2026.
https://www.floridablue.com/newsroom/florida-blue-expands-cancer-support-for-medicare-advantage-members
Articles in this issue
about 2 months ago
IRA, 340B, Medicaid: The Policy Pressures on Community OncologyRelated to this article




